Polycythemia Vera (PV)
Also known as: Polycythemia Vera / Polycythaemia vera / Polycytemia Vera / [M]Polycythemia vera (morphologic abnormality) / Primary polycythaemia / Vaquez's disease / Erythremia (morphologic abnormality) / Primary polycythemia / Polycythemia rubra vera / Polycythaemia rubra vera / Polycythemia vera (disorder) / Polycythemia vera (morphologic abnormality) / Polycythemia vera -RETIRED- / (Solitary myeloma) or (polycythaemia [rubra] vera) or (other uncertain neoplasms NOS)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00945 | Acetylsalicylic acid | A salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events. |
| DB01008 | Busulfan | An alkylating agent used to treat chronic myelogenous leukemia. |
| DB01005 | Hydroxyurea | An antimetabolite used to treat sickle cell anemia crisis. |
| DB00888 | Mechlorethamine | An antineoplastic agent used to treat Hodgkin's disease, lymphosarcoma, and chronic myelocytic or lymphocytic leukemia. |
| DB11697 | Pacritinib | A kinase inhibitor used for the treatment of primary and secondary myelofibrosis in adult patients with significantly reduced platelet counts. |
| DB15119 | Ropeginterferon alfa-2b | A mono-pegylated type I interferon used to treat polycythemia vera. |